Tapewire

NYSE · USD

IQV

IQVIA HOLDINGS INC.

Export transactions ↓
Tapewire entity
3058
SEC CIK
0001478242
Parsed reports
432

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202607
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 23, 2025 Filed Jul 25, 2025 21:00 UTC
Sherbet EricSee Remarks
Exercise / conversionCommon Stock 11,870 $97.20 $1,153,764.00
Disclosure

SEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,978

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:50 UTC GrantDeferred Shares · Derivative 196 $153.30 $30,046.80
Disclosure

SEC source: 0001478242-25-000092 · wk-form4_1746823810.xml · derivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,465

Underlying: Common Stock · 196 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:51 UTC GrantDeferred Shares · Derivative 179 $153.30 $27,440.70
Disclosure

SEC source: 0001478242-25-000095 · wk-form4_1746823897.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,452

Underlying: Common Stock · 179 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:50 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 244 $153.30 $37,405.20
Disclosure

SEC source: 0001478242-25-000093 · wk-form4_1746823842.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,683

Underlying: Common Stock · 244 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:51 UTC GrantDeferred Shares · Derivative 229 $153.30 $35,105.70
Disclosure

SEC source: 0001478242-25-000094 · wk-form4_1746823870.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,347

Underlying: Common Stock · 229 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:20 UTC GrantCommon Stock 1,592 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000075 · wk-form4_1745619562.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 29,041

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:20 UTC
Burt CarolDirector
GrantDeferred Shares · Derivative 1,592 $150.68 $239,882.56
Disclosure

SEC source: 0001478242-25-000076 · wk-form4_1745619632.xml · derivative · entry 1

Burt Carol · CIK 0001493926 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,639

Underlying: Common Stock · 1,592 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:19 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 1,592 $150.68 $239,882.56
Disclosure

SEC source: 0001478242-25-000074 · wk-form4_1745619534.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,439

Underlying: Common Stock · 1,592 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:18 UTC GrantCommon Stock 1,592 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000073 · wk-form4_1745619500.xml · nonDerivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,882

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:17 UTC GrantCommon Stock 1,592 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000072 · wk-form4_1745619471.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,375

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:17 UTC GrantDeferred Shares · Derivative 1,592 $150.68 $239,882.56
Disclosure

SEC source: 0001478242-25-000071 · wk-form4_1745619438.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,273

Underlying: Common Stock · 1,592 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 24, 2025 Filed Apr 25, 2025 22:16 UTC GrantDeferred Shares · Derivative 1,592 $150.68 $239,882.56
Disclosure

SEC source: 0001478242-25-000070 · wk-form4_1745619404.xml · derivative · entry 1

Stamps Sheila A · CIK 0001600782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,639

Underlying: Common Stock · 1,592 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:13 UTC Tax withholdingCommon Stock 16 $206.97 $3,311.52
Disclosure

SEC source: 0001478242-25-000038 · wk-form4_1739398372.xml · nonDerivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,459

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:13 UTC
Patel BhavikSee Remarks
Tax withholdingCommon Stock 108 $206.97 $22,352.76
Disclosure

SEC source: 0001478242-25-000039 · wk-form4_1739398407.xml · nonDerivative · entry 1

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,124

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:14 UTC
STAUB W RICHARDSee Remarks
Tax withholdingCommon Stock 141 $206.97 $29,182.77
Disclosure

SEC source: 0001478242-25-000041 · wk-form4_1739398467.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,896

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:14 UTC
Sherbet EricSee Remarks
Tax withholdingCommon Stock 179 $206.97 $37,047.63
Disclosure

SEC source: 0001478242-25-000040 · wk-form4_1739398438.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,108

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:12 UTC Tax withholdingCommon Stock 907 $206.97 $187,721.79
Disclosure

SEC source: 0001478242-25-000037 · wk-form4_1739398341.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,569

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:11 UTC
BOUSBIB ARIDirector · See Remarks
Exercise / conversionStock Appreciation Right · Derivative 40,000 $65.16 Strike: $65.16 $2,606,400.00
Disclosure

SEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · derivative · entry 5

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:11 UTC
BOUSBIB ARIDirector · See Remarks
Tax withholdingCommon Stock 3,335 $206.97 $690,244.95
Disclosure

SEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · nonDerivative · entry 3

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 807,163

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:11 UTC
BOUSBIB ARIDirector · See Remarks
Disposition to issuerCommon Stock 26,585 $206.97 $5,502,297.45
Disclosure

SEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · nonDerivative · entry 2

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 810,498

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 10, 2025. The transaction occurred between the reporting person and the issuer and did not involve a sale or other transaction with the market.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:11 UTC
BOUSBIB ARIDirector · See Remarks
Exercise / conversionCommon Stock 40,000 $65.16 $2,606,400.00
Disclosure

SEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 837,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 10, 2025. The transaction occurred between the reporting person and the issuer and did not involve a sale or other transaction with the market.

Read SEC document
February 05, 2025 Filed Feb 8, 2025 00:03 UTC GrantDeferred Shares · Derivative 146 $205.44 $29,994.24
Disclosure

SEC source: 0001478242-25-000027 · wk-form4_1738973030.xml · derivative · entry 3

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,269

Underlying: Common Stock · 146 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 05, 2025 Filed Feb 8, 2025 00:03 UTC GrantDeferred Shares · Derivative 134 $205.44 $27,528.96
Disclosure

SEC source: 0001478242-25-000026 · wk-form4_1738972979.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,681

Underlying: Common Stock · 134 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 05, 2025 Filed Feb 8, 2025 00:02 UTC GrantDeferred Shares · Derivative 170 $205.44 $34,924.80
Disclosure

SEC source: 0001478242-25-000025 · wk-form4_1738972948.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,118

Underlying: Common Stock · 170 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 05, 2025 Filed Feb 8, 2025 00:01 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 171 $205.44 $35,130.24
Disclosure

SEC source: 0001478242-25-000024 · wk-form4_1738972909.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,847

Underlying: Common Stock · 171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 05, 2025 Filed Feb 8, 2025 00:01 UTC GrantDeferred Shares · Derivative 133 $205.44 $27,323.52
Disclosure

SEC source: 0001478242-25-000023 · wk-form4_1738972883.xml · derivative · entry 1

CONNAUGHTON JOHN · CIK 0001213395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133

Underlying: Common Stock · 133 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC GrantStock Appreciation Right · Derivative 2,633 $0.00 Strike: $203.43 $0.00
Disclosure

SEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · derivative · entry 4

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,633

Underlying: Common Stock · 2,633 shares

Expires 2035-01-28

F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC Tax withholdingCommon Stock 176 $203.43 $35,803.68
Disclosure

SEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · nonDerivative · entry 3

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC GrantCommon Stock 2,457 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · nonDerivative · entry 2

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,651

F2 · shares: Represents a grant of restricted stock units that will vest 100% on the third anniversary of the date of grant.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC GrantCommon Stock 441 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · nonDerivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,194

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10 and July 28, 2022. The performance conditions applicable to the awards were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:56 UTC
Patel BhavikSee Remarks
GrantStock Appreciation Right · Derivative 10,534 $0.00 Strike: $203.43 $0.00
Disclosure

SEC source: 0001478242-25-000010 · wk-form4_1738277790.xml · derivative · entry 3

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,534

Underlying: Common Stock · 10,534 shares

Expires 2035-01-28

F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:56 UTC
Patel BhavikSee Remarks
Tax withholdingCommon Stock 612 $203.43 $124,499.16
Disclosure

SEC source: 0001478242-25-000010 · wk-form4_1738277790.xml · nonDerivative · entry 2

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,232

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:56 UTC
Patel BhavikSee Remarks
GrantCommon Stock 1,299 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000010 · wk-form4_1738277790.xml · nonDerivative · entry 1

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10 and July 28, 2022. The performance conditions applicable to the awards were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC
STAUB W RICHARDSee Remarks
GrantStock Appreciation Right · Derivative 24,580 $0.00 Strike: $203.43 $0.00
Disclosure

SEC source: 0001478242-25-000011 · wk-form4_1738277831.xml · derivative · entry 3

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,580

Underlying: Common Stock · 24,580 shares

Expires 2035-01-28

F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC
STAUB W RICHARDSee Remarks
Tax withholdingCommon Stock 479 $203.43 $97,442.97
Disclosure

SEC source: 0001478242-25-000011 · wk-form4_1738277831.xml · nonDerivative · entry 2

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,037

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:57 UTC
STAUB W RICHARDSee Remarks
GrantCommon Stock 1,571 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000011 · wk-form4_1738277831.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,516

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC
Sherbet EricSee Remarks
GrantStock Appreciation Right · Derivative 14,045 $0.00 Strike: $203.43 $0.00
Disclosure

SEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · derivative · entry 3

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,045

Underlying: Common Stock · 14,045 shares

Expires 2035-01-28

F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC
Sherbet EricSee Remarks
Tax withholdingCommon Stock 605 $203.43 $123,075.15
Disclosure

SEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · nonDerivative · entry 2

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,287

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC
Sherbet EricSee Remarks
GrantCommon Stock 2,356 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,892

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC GrantStock Appreciation Right · Derivative 31,603 $0.00 Strike: $203.43 $0.00
Disclosure

SEC source: 0001478242-25-000008 · wk-form4_1738277713.xml · derivative · entry 4

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,603

Underlying: Common Stock · 31,603 shares

Expires 2035-01-28

F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC Tax withholdingCommon Stock 2,201 $203.43 $447,749.43
Disclosure

SEC source: 0001478242-25-000008 · wk-form4_1738277713.xml · nonDerivative · entry 2

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,476

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC GrantCommon Stock 6,286 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000008 · wk-form4_1738277713.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,677

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:54 UTC
BOUSBIB ARIDirector · See Remarks
GrantStock Appreciation Right · Derivative 73,741 $0.00 Strike: $203.43 $0.00
Disclosure

SEC source: 0001478242-25-000007 · wk-form4_1738277667.xml · derivative · entry 4

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,741

Underlying: Common Stock · 73,741 shares

Expires 2035-01-28

F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:54 UTC
BOUSBIB ARIDirector · See Remarks
Tax withholdingCommon Stock 10,500 $203.43 $2,136,015.00
Disclosure

SEC source: 0001478242-25-000007 · wk-form4_1738277667.xml · nonDerivative · entry 2

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 797,083

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:54 UTC
BOUSBIB ARIDirector · See Remarks
GrantCommon Stock 22,000 $0.00 $0.00
Disclosure

SEC source: 0001478242-25-000007 · wk-form4_1738277667.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 807,583

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Read SEC document
December 03, 2024 Filed Feb 8, 2025 00:03 UTC PurchaseCommon Stock 1,275 $200.58 $255,739.50
Disclosure

SEC source: 0001478242-25-000027 · wk-form4_1738973030.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 1,275

F1 · acquired: The purchase of shares was made without Mr. Danhakl's knowledge by an independent financial broker/advisor who manages the purchasing entity.

F2 · ownership.nature: Shares held by an LLC controlled by the Danhakl Revocable Family Trust.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 22:00 UTC GrantDeferred Shares · Derivative 135 $221.25 $29,868.75
Disclosure

SEC source: 0001478242-24-000122 · wk-form4_1731103238.xml · derivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,123

Underlying: Common Stock · 135 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 22:02 UTC GrantDeferred Shares · Derivative 124 $221.25 $27,435.00
Disclosure

SEC source: 0001478242-24-000125 · wk-form4_1731103345.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,547

Underlying: Common Stock · 124 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 22:01 UTC GrantDeferred Shares · Derivative 158 $221.25 $34,957.50
Disclosure

SEC source: 0001478242-24-000124 · wk-form4_1731103312.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,948

Underlying: Common Stock · 158 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 22:01 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 158 $221.25 $34,957.50
Disclosure

SEC source: 0001478242-24-000123 · wk-form4_1731103281.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,676

Underlying: Common Stock · 158 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.